Adaptive Biotechnologies (NASDAQ:ADPT) 報告季度每股虧損$(0.23)，優於分析師共識預期的$(0.26)，超出11.54%。公司報告季度銷售額$47.459百萬，超過分析師共識預期的$46.034百萬，超出3.09%。相比去年同期的$45.784百萬，銷售額增長了3.66%。

以上內容來自Benzinga Earnings專欄，原文如下：

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.26) by 11.54 percent. The company reported quarterly sales of $47.459 million which beat the analyst consensus estimate of $46.034 million by 3.09 percent. This is a 3.66 percent increase over sales of $45.784 million the same period last year.